Infanrix™
Sponsors
GlaxoSmithKline
Conditions
Acellular PertussisDiphtheriaHaemophilus Influenzae Type bHepatitis AInfections, RotavirusTetanus
Phase 3
Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months
CompletedNCT00197236
Start: 2003-11-11End: 2007-12-03Updated: 2018-08-20
Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children
CompletedNCT00696423
Start: 2008-06-07End: 2008-07-26Updated: 2018-06-06
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
CompletedNCT01000974
Start: 2010-06-18End: 2013-07-17Updated: 2018-07-12
Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants
CompletedNCT01171963
Start: 2010-08-29End: 2012-05-12Updated: 2018-08-06